Hims & Hers Health (HIMS) shares declined 0.91% to $30.64 on Monday, even as the company announced a nationwide expansion of its women's healthcare services in Australia. The stock lost $0.28 during regular trading before slipping another 0.13% to $30.60 in after-hours trading.

The pullback came on the same day Hims & Hers confirmed the official Australian launch of its Hers platform on October 12, expanding access to personalized healthcare services for Australian women and broadening the telehealth company's international operations. The company said the service introduces round-the-clock care and personalized treatments for women nationwide. Hers is the company's women-focused brand, completing a two-brand structure in Australia alongside Hims.

Hers Launches Nationwide Across Australia

The Hers platform offers treatments covering weight management, hair regrowth, menopause, and perimenopause through digital consultations. Women using the service can access healthcare professionals, receive medication support, and reach a dedicated care team available around the clock.

The expansion follows Hims & Hers' acquisition of Eucalyptus earlier this year, a deal that strengthened the company's position in Australia's digital healthcare sector. Under the transition, Eucalyptus' existing women's healthcare platform, Juniper, will operate under the Hers brand. The company had already rebranded Pilot to Hims in August, completing its broader Australian platform rollout. Taken together, the sequence converts an acquired local operator into the company's own brand architecture, an approach that lets Hims & Hers enter a market with established practitioners and patient bases already in place.

As part of the launch, the company introduced specialized weight management programs that combine medical treatment with nutritional guidance and fitness support. Hers also provides hair regrowth treatments and services addressing hormonal health concerns throughout different life stages. Patients can request female practitioners and join a community of more than 27,000 women.

Hers Targets Healthcare Access Gaps With Digital Treatment Programs

Hers plans to address healthcare access challenges affecting women across Australia's metropolitan and regional communities. According to company research, 52% of surveyed Australian women reported experiencing weight-related judgment from healthcare professionals. Among those respondents, 72% subsequently avoided seeking clinical assistance, a finding the company said highlights barriers to routine treatment.

The company also identified healthcare costs and geographic limitations as obstacles to accessing specialized medical services. Nearly 30% of Australians live in regional and rural communities, where specialist appointments can require extended waiting periods. Hers aims to bridge this gap by connecting patients with medical professionals through remote consultations and continuous digital support.

Rebecca Holdt, the company's international product vice president, emphasized digital healthcare's role in improving nationwide access to treatment. Meanwhile, Australian Chief Medical Officer Matt Vickers highlighted the need for evidence-based services that address women's broader healthcare requirements. Existing Juniper patients will retain their Australian practitioners while gaining access to additional treatment options.

Australia Expansion Strengthens International Operations

The Australian launch extends Hims & Hers' existing international presence across North America and Europe. It also places the company in a growing telehealth market where demand for accessible digital healthcare services is increasing. Industry projections cited by the company estimate Australia's telehealth market could reach $2.56 billion by 2034.

Gus Wood will oversee Australian operations as general manager, supported by Chief Medical Officer Matt Vickers. Jessica Shepherd, chief medical officer of Hers, will provide clinical oversight to maintain the company's international healthcare standards. According to the company, the leadership structure combines local medical expertise with its wider technology and treatment infrastructure.

With the rollout complete, the near-term markers of the strategy are concrete: how existing Juniper patients transition under the Hers brand, uptake of the newly introduced weight management programs, and engagement across the community the company currently counts at more than 27,000 women.

Despite the expansion, Hims & Hers Health stock ended Monday's session lower and extended its losses into after-hours trading. The latest rollout broadens the company's healthcare offerings beyond its existing services and establishes a unified brand across Australia. However, Monday's stock decline contrasted with the company's continued expansion into international digital healthcare markets.

Source: Blockonomi